Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Pulmozyme Market Report 2025

Pulmozyme Global Market Report 2025 – By Indication (Cystic Fibrosis, Respiratory Tract Infections), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By End User (Hospitals And Clinics, Homecare Settings) – Market Size, Trends, And Global Forecast 2025-2034

Pulmozyme Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Pulmozyme Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Pulmozyme Market Definition

Pulmozyme (Dornase alfa) is a recombinant human deoxyribonuclease I (DNase I) enzyme used primarily in the treatment of Cystic Fibrosis (CF). It works by breaking down DNA in the thick mucus secretions present in the lungs of patients, reducing mucus viscosity and improving lung function. Delivered via a nebulizer, Pulmozyme improves lung function, facilitates easier breathing, and lowers the risk of respiratory infections.

The main indications for pulmozyme are cystic fibrosis, and respiratory tract infections. A genetic disorder causes thick, sticky mucus to accumulate in the lungs and digestive system, leading to breathing difficulties and recurring lung infections. These are distributed through various distribution channels such as hospital pharmacies, retail pharmacies, online pharmacies and are used by various end-users such as hospitals and clinics, homecare settings

Pulmozyme Market Segmentation

The pulmozymemarket covered in this report is segmented –

1) By Indication: Cystic Fibrosis, Respiratory Tract Infections

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By End User: Hospitals And Clinics, Homecare Settings

Pulmozyme Market Size and growth rate 2025 to 2029: Graph

Pulmozyme Market Size 2025 And Growth Rate

The pulmozyme market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the expansion of reimbursement coverage, minimal competition, clinical evidence of efficacy, approval by the FDA, and clinical adoption.

Pulmozyme Market Growth Forecast

The pulmozyme market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the adoption of neonatal screening programs, increased investment in rare disease therapies, advances in genetic profiling, rising healthcare infrastructure, and genomic advances. Major trends in the forecast period include advancements in homecare settings, advancements in drug delivery systems, integration of digital health technologies, development of patient-friendly formulations, and research in enzyme therapy.

Book your 30 minutes free consultation with our research experts

Contact Us

Pulmozyme Market Driver: Rising Respiratory Disorders Fuel Pulmozyme Demand

The rise in respiratory disorders is expected to propel the growth of the pulmozyne market going forward. Respiratory disorders are medical conditions affecting the lungs and airways, impairing breathing and oxygen exchange, including diseases such as asthma, COPD, and pneumonia. The rise in respiratory disorders is driven by increasing air pollution, smoking, occupational hazards, climate change, and higher prevalence of allergens and infectious diseases. Pulmozyme (dornase alfa) is used to manage respiratory disorders such as cystic fibrosis by breaking down thick mucus in the lungs, improving airflow and reducing infection risk. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, approximately 8.5 million people in Australia, or 34% of the population, were estimated to have chronic respiratory conditions. This includes an estimated 2.8 million people, or 11% of the population, living with asthma, and 638,000 people, or 2.5% of the population, living with chronic obstructive pulmonary disease (COPD). Therefore, the rise in respiratory disorders drives the pulmozyme market.

Pulmozyme Market Driver: Pulmozyme Market Gains Momentum With Rising Lung Transplants

The rise in the number of lung transplants is expected to propel the growth of the pulmozyme market going forward. A lung transplant is a surgical procedure in which a diseased or failing lung is replaced with a healthy donor lung to treat severe respiratory failure or chronic lung diseases. The rise in number of lung transplants is due to an increase in the prevalence of chronic respiratory diseases such as cystic fibrosis and COPD, improved surgical techniques, and advancements in post-transplant care that enhance survival rates. Pulmozyme, a recombinant human DNase enzyme, helps lung transplant patients by breaking down the thick, sticky mucus in their airways, reducing the risk of infections and improving lung function, which ultimately aids in enhancing their ability to breathe and maintain respiratory health post-transplant. For instance, in August 2023, National Health Services (NHS) a UK-based healthcare system, the total number of UK citizens with active lung and heart-lung transplants in 2022 accounted for 267 which increased to 302 in 2023. Therefore, the increase in the number of lung transplants drives the pulmozyme market.

Pulmozyme Market Driver: Healthcare Expenditure Fuels Pulmozyme Market Growth

The rise in healthcare expenditure is expected to propel the growth of pulmozyme market going forward. Healthcare expenditure refers to the total amount of financial resources spent on medical services, healthcare infrastructure, pharmaceuticals, and healthcare-related activities. Healthcare expenditure is rising due to factors such as an aging population, increasing prevalence of chronic and lifestyle-related diseases, advances in medical technology, and greater access to healthcare services. Healthcare expenditure supports pulmozyme by funding the development, production, and distribution of this specialized enzyme therapy, ensuring its availability to patients with cystic fibrosis, facilitating reimbursement policies that make it accessible to those in need, and promoting continued research to enhance its efficacy and broaden its clinical applications. For instance, in May 2024, according to a report published by Office For National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the increase in healthcare expenditure drives the pulmozyme market.

Global Pulmozyme Market Major Players

Major companies operating in the pulmozyme market include Roche Holding AG

Regional Outlook For The Global Pulmozyme Market

North America was the largest region in the pulmozyme market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pulmozyme market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pulmozyme market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Pulmozyme Market?

The pulmozyme market consists of sales of inhalation solutions, nebulizer solutions, and injectable solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pulmozyme Industry?

The pulmozyme market research report is one of a series of new reports from The Business Research Company that provides pulmozyme market statistics, including pulmozyme industry global market size, regional shares, competitors with a pulmozyme market share, detailed pulmozyme market segments, market trends, and opportunities, and any further data you may need to thrive in the pulmozyme industry. This pulmozyme market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pulmozyme Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 CAGR of from 2025 to 2034
Revenue Forecast In 2034 2024
Growth Rate 2019-2024
Base Year For Estimation 2025 - 2029 - 2034
Actual Estimates/Historical Data Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period 1) By Indication: Cystic Fibrosis, Respiratory Tract Infections
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By End User: Hospitals And Clinics, Homecare Settings
Market Representation Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope Roche Holding AG
Country Scope Request for Sample
Key Companies Profiled Explore Purchase Options
Customization Scope
Pricing And Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Pulmozyme Market Characteristics

    3. Pulmozyme Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Pulmozyme Market Trends And Strategies

    5. Pulmozyme Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Pulmozyme Growth Analysis And Strategic Analysis Framework

    6.1. Global Pulmozyme PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Pulmozyme Market Growth Rate Analysis

    6.4. Global Pulmozyme Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    6.5. Global Pulmozyme Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    6.6. Global Pulmozyme Total Addressable Market (TAM)

    7. Global Pulmozyme Market Pricing Analysis & Forecasts

    8. Pulmozyme Market Segmentation

    8.1. Global Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cystic Fibrosis

    Respiratory Tract Infections

    8.2. Global Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Online Pharmacy

    8.3. Global Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals And Clinics

    Honecare Settings

    9. Global Pulmozyme Market Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Pulmozyme Market Regional And Country Analysis

    10.1. Global Pulmozyme Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. Global Pulmozyme Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Asia-Pacific Pulmozyme Market

    11.1. Asia-Pacific Pulmozyme Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Asia-Pacific Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Asia-Pacific Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. China Pulmozyme Market

    12.1. China Pulmozyme Market Overview

    12.2. China Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    12.3. China Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    12.4. China Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    13. India Pulmozyme Market

    13.1. India Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. India Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. India Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. Japan Pulmozyme Market

    14.1. Japan Pulmozyme Market Overview

    14.2. Japan Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. Japan Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. Japan Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Australia Pulmozyme Market

    15.1. Australia Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.2. Australia Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Australia Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. South Korea Pulmozyme Market

    16.1. South Korea Pulmozyme Market Overview

    16.2. South Korea Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. South Korea Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.4. South Korea Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Western Europe Pulmozyme Market

    17.1. Western Europe Pulmozyme Market Overview

    17.2. Western Europe Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Western Europe Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.4. Western Europe Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. UK Pulmozyme Market

    18.1. UK Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. UK Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. UK Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Germany Pulmozyme Market

    19.1. Germany Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Germany Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Germany Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. France Pulmozyme Market

    20.1. France Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. France Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. France Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Pulmozyme Market

    21.1. Eastern Europe Pulmozyme Market Overview

    21.2. Eastern Europe Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. North America Pulmozyme Market

    22.1. North America Pulmozyme Market Overview

    22.2. North America Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. North America Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.4. North America Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. USA Pulmozyme Market

    23.1. USA Pulmozyme Market Overview

    23.2. USA Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. USA Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. USA Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. Canada Pulmozyme Market

    24.1. Canada Pulmozyme Market Overview

    24.2. Canada Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. Canada Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. Canada Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. South America Pulmozyme Market

    25.1. South America Pulmozyme Market Overview

    25.2. South America Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. South America Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. South America Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. Middle East Pulmozyme Market

    26.1. Middle East Pulmozyme Market Overview

    26.2. Middle East Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. Middle East Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. Middle East Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Africa Pulmozyme Market

    27.1. Africa Pulmozyme Market Overview

    27.2. Africa Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Africa Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.4. Africa Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Pulmozyme Market Competitive Landscape And Company Profiles

    28.1. Pulmozyme Market Competitive Landscape

    28.2. Pulmozyme Market Company Profiles

    28.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

    29. Global Pulmozyme Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Pulmozyme Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Pulmozyme Market

    32. Recent Developments In The Pulmozyme Market

    33. Pulmozyme Market High Potential Countries, Segments and Strategies

    33.1 Pulmozyme Market In 2029 - Countries Offering Most New Opportunities

    33.2 Pulmozyme Market In 2029 - Segments Offering Most New Opportunities

    33.3 Pulmozyme Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Pulmozyme Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Pulmozyme Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Asia-Pacific, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Asia-Pacific, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: China, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: China, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: India, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: India, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Japan, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Japan, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Australia, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Australia, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: South Korea, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: South Korea, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: South Korea, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Western Europe, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Western Europe, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Western Europe, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: UK, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: UK, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: UK, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Germany, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Germany, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Germany, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: France, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: France, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: France, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Eastern Europe, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Eastern Europe, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Eastern Europe, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: North America, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: North America, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: North America, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: USA, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: USA, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: USA, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Canada, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Canada, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Canada, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: South America, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: South America, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: South America, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Middle East, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Middle East, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Middle East, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Africa, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Africa, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Africa, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Roche Holding AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Pulmozyme Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Pulmozyme Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Asia-Pacific, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Asia-Pacific, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: China, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: China, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: India, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: India, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Japan, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Japan, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Australia, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Australia, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: South Korea, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: South Korea, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: South Korea, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Western Europe, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Western Europe, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Western Europe, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: UK, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: UK, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: UK, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Germany, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Germany, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Germany, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: France, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: France, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: France, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Eastern Europe, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Eastern Europe, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Eastern Europe, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: North America, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: North America, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: North America, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: USA, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: USA, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: USA, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Canada, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Canada, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Canada, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: South America, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: South America, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: South America, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Middle East, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Middle East, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Middle East, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Africa, Pulmozyme Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Africa, Pulmozyme Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Africa, Pulmozyme Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Roche Holding AG Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

Latest Gynecology Drugs Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

Read More

Cystic Fibrosis (CF) Therapeutics Global Market Report 2025 – By Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators), By Route Of Administration (Oral, Inhaled), By Treatment Method (Medication, Devices) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Idiopathic Pulmonary Fibrosis Global Market Report 2025 – By Drug Type (Nintedanib, Pirfenidone, Other Drug Types), By Mode Of Action (Antifibrotic Agents, Tyrosine Kinase Inhibitors, Other Modes of Action), By Route Of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Providers), By End Users (Hospitals and Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Non-Cystic Fibrosis Bronchiectasis Global Market Report 2025 – By Diagnosis (Computed Tomography (CT) Scan, Bronchoscopy, Chest X Ray, Lung Function, Sputum Culture Test, Blood Tests, Other Diagnosis Types), By Treatment (Surgery, Physiotherapy, Vaccination, Airway Pharmacotherapy, Antibiotics, Other Treatments), By End Use (Hospitals And Clinics, Ambulatory Care Centers, Other End Uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Small Cell Lung Cancer Therapeutics Global Market Report 2025 – By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate, Pembrolizumab), By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Route Of Administration (Oral, Parenteral, Other Routes Of Administrations), By End-Users (Hospitals, Cancer Therapy Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Black Lung Disease Global Market Report 2025 – By Type (Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis, Other Types), By Treatment (Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell Therapy, Other Treatment), By Diagnosis (Biopsy, Imaging, Full Blood Count, Pulmonary Or Lung Function Tests, Physical Examination, Other Diagnosis), By End Users (Hospitals And Clinics, Research Organizations And Academic Institutes, Diagnostic Centers And Labs, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Interstitial Lung Disease Global Market Report 2025 – By Drug Type (Oral Corticosteroids, Immune Suppressing, Anti-Fibrotic Medication, Other Drugs), By Disease Type (Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonitis, Hypersensitivity Pneumonitis, Cryptogenic Organizing Pneumonia (COP), Sarcoidosis, Acute Interstitial Pneumonitis), By Application (Adults, Children), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Lung Cancer Drugs Global Market Report 2025 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Lung Cancer Diagnostic And Screening Global Market Report 2025 – By Product (Instruments, Consumables And Accessories), By Test (Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests), By Cancer Type (Non-Small Cell Lung Cancer, Small Cell Lung Cancer), By End User (Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Pulmozyme market?

Pulmozyme (Dornase alfa) is a recombinant human deoxyribonuclease I (DNase I) enzyme used primarily in the treatment of cystic fibrosis (CF). It works by breaking down DNA in the thick mucus secretions present in the lungs of patients, reducing mucus viscosity and improving lung function. Delivered via a nebulizer, Pulmozyme improves lung function, facilitates easier breathing, and lowers the risk of respiratory infections. For further insights on the Pulmozyme market, request a sample here

How will the Pulmozyme market drivers and restraints affect the market dynamics? What forces will shape the Pulmozyme industry going forward?

The Pulmozyme market major growth driver - Rising Respiratory Disorders Fuel Pulmozyme Demand. For further insights on the Pulmozyme market, request a sample here

What is the forecast market size or the forecast market value of the Pulmozyme market?

The Pulmozyme market size has grown strongly in recent years. The pulmozyme market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the expansion of reimbursement coverage, minimal competition, clinical evidence of efficacy, approval by the FDA, and clinical adoption. The pulmozyme market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the adoption of neonatal screening programs, increased investment in rare disease therapies, advances in genetic profiling, rising healthcare infrastructure, and genomic advances. Major trends in the forecast period include advancements in homecare settings, advancements in drug delivery systems, integration of digital health technologies, development of patient-friendly formulations, and research in enzyme therapy. For further insights on the Pulmozyme market, request a sample here

How is the Pulmozyme market segmented?

The pulmozymemarket covered in this report is segmented –
1) By Indication: Cystic Fibrosis; Respiratory Tract Infections
2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
3) By End User: Hospitals And Clinics; Homecare Settings For further insights on the Pulmozyme market, request a sample here

Which region has the largest share of the Pulmozyme market? What are the other regions covered in the report?

North America was the largest region in the pulmozyme market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pulmozyme market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Pulmozyme market, request a sample here.

Who are the major players in the Pulmozyme market?

Major companies operating in the pulmozyme market include Roche Holding AG . For further insights on the Pulmozyme market, request a sample here.

What are the key trends in the Pulmozyme market?

Major trends in the Pulmozyme market include . For further insights on the Pulmozyme market, request a sample here.

What are the major opportunities in the Pulmozyme market? What are the strategies for the Pulmozyme market?

For detailed insights on the major opportunities and strategies in the Pulmozyme market, request a sample here.

How does the Pulmozyme market relate to the overall economy and other similar markets?

For detailed insights on Pulmozyme's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Pulmozyme industry?

For detailed insights on the mergers and acquisitions in the Pulmozyme industry, request a sample here.

What are the key dynamics influencing the Pulmozyme market growth? SWOT analysis of the Pulmozyme market.

For detailed insights on the key dynamics influencing the Pulmozyme market growth and SWOT analysis of the Pulmozyme industry, request a sample here.